Company page

Relmada Therapeutics, Inc.

Relmada Therapeutics, Inc. (ticker: RLMD) is a public company based in the United States, with a market capitalization of approximately $756.3 million. The company focuses on developing innovative therapies for the treatment of pain and other central nervous system disorders. Relmada is committed to advancing its pipeline of drug candidates to address unmet medical needs in these areas.